BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
192 hedge funds and large institutions have $3.12B invested in bluebird bio in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 59 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
192
Holders Change
-43
Holders Change %
-18.3%
% of All Funds
5.37%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.11%
New
21
Increased
93
Reduced
59
Closed
63
Calls
$59.5M
Puts
$64M
Net Calls
-$4.52M
Net Calls Change
-$9.39M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$409M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
$52.7M |
| 3 |
O
OppenheimerFunds
New York
|
$96.5M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
$28.2M |
| 5 |
O
OrbiMed
New York
|
$102M |
